On June 16, Senate Finance Committee Democrats released an RFI on proposals to lower the cost of prescription drugs. On Aug. 17, AMCP submitted comments in response.
On August 28, Chairman Crapo announced that Secretary Kennedy would testify before the Senate Finance Committee to preview the Trump administration’s 2026 health care agenda, including the Make America Healthy Again (MAHA) initiative.
This was Secretary Kennedy’s first Congressional hearing since the passage of H.R. 1 on July 4. The bill introduced sweeping changes to Medicaid and the individual marketplace, most notably Medicaid community engagement requirements and restrictions on state financing mechanisms like provider taxes. You can read more about H.R. 1 on AMCP’s resource page.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.